RS Flashcards
Hounsfield units (HU) for CT thorax Air Fat Water Soft tissue Ca ion
Air: -1000 HU Fat: -20 (Wiki: -100 to -50) Water: 0 Soft tissue: 30-50 (Wiki: 100 to 300) Ca ion: >150
Ix for Pneumonia
- CBC
- L/RFT, Electrolytes (e.g. SIADH complicating pneumonia)
- ABG
- Atypical pneumonia serology
- NPA if suspect influenza
- Legionella urinary Ag test
- Sputum culture
- Blood cultures
CURB-65 for pneumonia
C: Confusion U: Urea >7mmol/L R: RR>30 B: SBP<90 or DBP<60 Age >65 Any 3+ --> Hospitalization
CAP Tx
General therapy
Empirical ABX: Augmentin +/- Marcolide or Tetracycline
General therapy for pneumonia
- O2 for Type 1 RS failure; Mechanical ventilation for Type 2
- Chest physiotherapy
- Fluid rehydration
- Treat underlying COPD with bronchodilators
- Control cardiac arrhythmias (e.g. AF)
Cx of Pneumonia
- RS failure
- Septicemia
- Parapneumonic effusion
- Lung abscess
- Empyema thoracis
- SIADH
- AMI
- Cardiac arrhythmias, e.g. AF
Ix for Bronchiectasis
- CXR
- HRCT
- Igs
- Auto-Abs
- Barium studies, 24h esophageal monitoring for gastric reflux
- Ciliary and sperm analysis for ciliary dyskinesia
- Neutrophil fx
- Sweat test for CF
Tx for Bronchiectasis
- ICS +/- LABA
2. Long term Macrolide for immunomodulating effect
Sx of OSA
- Snoring
- Excessive daytime sleepiness
- Witness apneas
- Nocturnal choking
- Restless sleep
- Unrefreshing sleep, morning headache
- Irritability, intellectual deterioration, poor concentration
- ↓Libido
- Enuresis, nocturia
GINA symptom control (Global initiative for Asthma)
In past 4 weeks, 1. Daytime asthma symptoms >2 per week 2. Night waking due to asthma 3. Reliever needed for symptoms >2 per week 4. Activity limitation due to asthma Well controlled = 0 Partly controlled = 1-2 Uncontrolled = 3-4
Relievers for Asthma
- SABA (Salbutamol, Terbutaline)
- LABA (Salmeterol, Formoterol)
- Xanthines (PDE inhibitor)
- Anti-cholinergics
Preventers for Asthma
- ICS / Oral steroids
- Leukotriene receptor antagonist
- Anti-IgE Ab (Omalizumab)
For pedi: Nedocromial sodium (mast cell stabilizer), Sodium cromoglycate
Pleural effusion causes
Fluid overload 1. CHF 2. Renal failure Hypoalbuminemia 3. Cirrhosis 4. Nephrotic syndrome 5. Severe malnutrition Pleural inflammation (--> Increase cap permeability) 6. TB, Pneumonia 7. SLE 8. CA lung 9. Pancreatitis / Liver abscess Decreased lymphatic drainage 10. Malignant infiltration 11. Necrotizing infection
Ix for Pleural effusion
Diagnostic thoracocentesis + pleural fluid analysis 1. Appearance 2. Chemistry (Light's criteria) 3. Cell count, differential (PMN or Lymphocytes) 4. Cytology (Malig) 5. Microbiology (Smear, culture, AFB) Treat organ failure if Transudative Further Ix if Exudative, by -Percutaneous pleural biopsy -Thoracoscopy, Pleuroscopy
Top 3 DDx for Exudative
Infection
Malignancy
Systemic inflammation
Rivalta test
For pleural fluid
Disappear = Negative (Transudative)
Precipitates = Positive (Exudative)
Sx of CA Lung
Constitutional symptoms: Malaise, LOA, LOW
Due to primary lesion (bronchial mucosa ulceration) –> Cough, sputum, hemoptysis
Due to primary lesion (obstructive) –> Wheeze, unresolved pneumonia, dyspnea
Due to intrathoracic spread
1. Lymphangitis carcinomatosis (spread along
lymphatics to both lungs) –> Cough, SOB
2. Pleura, Pleural effusion –> Chest pain, SOB
3. Pericardial effusion –> Cardiac tamponade –> SOB
4. SVCO –> Dyspnea, stridor, dysphagia, face swelling
5. L. recurrent laryngeal n. –> Hoarseness of voice
6. Brachial plexus (C8, T1, T2) and inferior cervical sym. ganglion (Horner’s) –> Pain in shoulder and arm; loss of sweating on 1 side of face
7. Esophagus –> Dysphagia
8. Chest wall and ribs –> Chest pain, swelling
*RLN can only be due to left lung cancer (no intrathoracic course of right RLN)
Horner syndrome
- Partial ptosis
- Miosis
- Anhidrosis
- Pseudo-enophthalmos
Signs of extra-thoracic manifestation of CA Lung
- Cachexia
- Finger clubbing
- Supraclavicular, Cervical LNs enlarged
- Liver, brain, bone, adrenal, spinal cord, skin, choroidal metastasis
Liver –> Hepatomegaly, deranged LFT
Brain –> Seizure, change in personality, vomiting
Bone –> Pathological fractures, hyperCa, bone pain
Adrenal –> Cortisol insufficiency (rare)
Spinal cord –> Cord compression
Choroidal –> Impaired visual acuity - Unexplained anemia
Lambert–Eaton myasthenic syndrome
AI disease, Abs against presynaptic voltage-gated Ca channels
Muscle weakness, legs more affected
Underlying lung SCLC
Also asso w/ DM type 1, hypothyroidism
Cx of COPD
- Acute exacerbation
- Chronic RS failure
- Cor pulmonale
- Chronic hypoxemia –> Pul HT –> RVH and RVF
- Pul thromboembolism
- Blood: Sec polycythemia
- Circulatory: Cor pulmonale, backlogging of blood, slow circulation
- Bedrest
Ix for COPD
- Lung function test
- FEV1/FVC (<70% - airflow obs)
- Increase RV, TLC
- Decrease DLCO
- CBC
- CXR
- ABG (for RS failure)
- Sputum (for infection)
- ECG +/- Echo (for Cor pulmonale)
Mx of COPD
- Quit smoking
- Manage stable COPD
- Bronchodilators, ICS
- Long term O2 therapy
- Rehabilitation + Flu / Pneumococcal vaccine
- Manage acute exacerbation
- Controlled O2 therapy
- ABX
- Non-invasive ventilation (for type 2 RS failure)
- Manage exacerbation (Cor pulmonale)
- Diuretics, fluid restriction
Hypercapnia = Hypercarbia
> _>
Hypoventilation
- Depressed CNS in Barbiturate overdose
2. Neuromuscular or skeletal deformity with restriction of chestwall movement (MG, Kyphoscoliosis)
Examples of Type 1 RS failure
Oxygenation failure (only decrease PO2)
V-Q imbalance 1. COPD 2. Asthma 3. ILD (IPF) Shunting 4. Pul edema 5. ARDS 6. Major lung collapse
Examples of Type 2 RS failure
Hypoventilation (with early elevated pCO2)
- CNS disease, Barbiturate overdose
- MG, Kyphoscoliosis
V-Q imbalance
3. Severe COPD or acute exacerbation of COPD
Pathophysio of COPD causing RS failure
- V-Q mismatch
- Alveolar hypoventilation
- Shunting
Dx of Cor pulmonale
- Clinical features of Pul HT, RVH, RVF
- Underlying COPD
- RHF where there is AE of chronic RS problem
- RS failure (Type 1 or 2)
- CXR showing dilated pulmonary trunks at hila, RV dilatation
- ECG shows P pulmonale (spiky P), RAD, RVH
- Echo (usu not done)
SE of Salbutamol
(Wiki)
Fine tremor, anxiety, headache, muscle cramps, dry mouth, and palpitation.
Tachycardia, arrhythmia, flushing of the skin, myocardial ischemia (rare), and disturbances of sleep and behaviour
Haemophilus influenzae
流感嗜血桿菌
Gram negative
Coccobacilli
Facultative anaerobe
Mycoplasma pneumoniae
肺炎支原體/黴漿菌性肺炎
Absence of a peptidoglycan cell wall
Asso w/ Cold agglutinin disease
Chlamydophila pneumoniae
Obligate intracellular bacterium
Atypical pneumonia
- Mycoplasma pneumoniae
- Chlamydophila pneumoniae
- Legionella pneumophila
Paraneoplastic for CA Lung
- Connective tissue – clubbing, hypertrophic pulmonary osteoarthropathy –> Arthralgia, pain, tenderness of extremities
- Ectopic hormones
- ADH –> ↓Na –> Confusion, weakness
- ACTH –> ↓K –> Weakness
- PTH like peptide –> ↑Ca –> Polyuria, thirst, confusion - Neuromuscular
- Encephalopathy –> Dementia, confusion
- Cerebellar degeneration -> Ataxia, clumsiness
- Peripheral neuropathy –> Paresthesia, weakness
- Myasthenia-like (Eaton-Lambert)
- Dermatomyositis
EGFR inhibitors for CA lung
TKI
- Erlotinib (Tarceva)
- Gefitinib (Iressa)
Monoclonal Ab against EGFR
- Cetuximab
VEGF inhibitors for CA lung
Anti-VEGF (vascular endothelial growth factor)
- Bevacizumab
SE of Isoniazid (H)
- Hepatotoxicity
- Peripheral neuropathy
- Psychosis, epilepsy
SE of Rifampicin (R)
- Red-orange discoloration of urine
- Hepatotoxicity
- Flu syndrome
SE of Pyrazinamide (Z)
- Gout
- Frozen shoulder
- Hepatotoxicity
- Rash
SE of Ethambutol (E)
- Optic neuritis (aka retrobulbar neuritis)
2. Gout
SE of Streptomycin (S)
- Ototoxicity
- Avoid in preg
- Nephrotoxicity
MDR-TB
Resistant to at least Isoniazid and Rifampicin
XDR-TB
Resistant to at least Isoniazid + Rifampicin + any quinolones + at least 1 of 2nd line injectables (Kanamycin, Capreomycin, Amikacin)
Chemotherapy for NSCLC (30-40% response rate)
- Cyclical combination chemo
- Add Platinum based drug (Cisplatin, Carboplatin) to increase efficacy
- Tgt with newer generation of cytotoxic drug (Paclitaxel, Gemcitabine, Vinorelbine, Pemetrexed)
- SE: Myelosuppression
Targeted therapy for CA lung: Ind, choice
Indications
- Primary tx for tumor with oncogenic molecular targets
- For patients not tolerating or accepting risk of chemo
EGFR-TKI (Gefitinib, Erlotinib)
- Especially for adenoCA, women, non-smoker, with activating EGFR mutations
- Distinct SE = Acneiform skin rash
- New targets with new therapy: EML4-ALK rearrangement gene with ALK inhibitor (Crizotinib) and ROS1 rearrangement (use when TKI resistance)
- Use chemo if no EGFR mutation
SOCRATES
Site Onset Character Radiation Association Time Exa/Relieving Severity
Churg-Strauss syndrome
aka Eosinophilic granulomatosis with polyangiitis Asthma/AR Eosinophilia Vasculitis ANCA
Nikolsky’s sign
Present when slight rubbing of the skin results in exfoliation of the outermost layer
- Stevens-Johnson Syndrome/toxic epidermal necrolysis
- Staphylococcal scalded skin syndrome
- Pemphigus vulgaris
Azathioprine and Allopurinol
Cannot be used tgt
Allergic contact dermatitis test
Skin patch test
Type 4 HS
Atopic dermatitis
aka Atopic eczema
Skin prick test
Type 1 HS